{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:01:28Z","timestamp":1791820888871,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd012693","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000}}],"reference-count":108,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012693.pub2","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T08:29:47Z","timestamp":1517473787000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)"],"prefix":"10.1002","volume":"2018","author":[{"given":"Sarah F","family":"Lensen","sequence":"first","affiliation":[{"name":"University of Auckland; Department of Obstetrics and Gynaecology; Park Rd Grafton Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Manchester Academic Health Science Centre (MAHSC), University of Manchester; Centre for Biostatistics, School of Health Sciences, Faculty of Biology, Medicine and Health; Clinical Sciences Building Salford Royal NHS Foundation Trust Hospital Room 1.315, Jean McFarlane Building University Place Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jori A","family":"Leijdekkers","sequence":"additional","affiliation":[{"name":"University Medical Center; Department of Reproductive Medicine and Gynecology; Oudegracht 150 bis Utrecht Netherlands 3511 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"La Marca","sequence":"additional","affiliation":[{"name":"University of Modena and Reggio Emilia, Clinica Eugin; Mother-Infant Department; Via Universit\ufffd 4 Modena Italy 41121"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben Willem J","family":"Mol","sequence":"additional","affiliation":[{"name":"The University of Adelaide; Discipline of Obstetrics and Gynaecology, School of Medicine, Robinson Research Institute; Level 3, Medical School South Building Frome Road Adelaide South Australia Australia SA 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Marjoribanks","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Obstetrics and Gynaecology; Park Rd Grafton Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Torrance","sequence":"additional","affiliation":[{"name":"University Medical Center; Department of Reproductive Medicine and Gynecology; Oudegracht 150 bis Utrecht Netherlands 3511 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J","family":"Broekmans","sequence":"additional","affiliation":[{"name":"University Medical Center; Department of Reproductive Medicine and Gynecology; Oudegracht 150 bis Utrecht Netherlands 3511 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD012693.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.rbmo.2017.01.012","article-title":"A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF\/ICSI cycles","volume":"34","author":"Allegra","year":"2017","journal-title":"Reproductive Biomedicine Online"},{"issue":"6","key":"10.1002\/14651858.CD012693.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose response trial in women undergoing in vitro fertilization\/ intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","article-title":"A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response","volume":"203","author":"Bastu","year":"2016","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"2","key":"10.1002\/14651858.CD012693.pub2-BIB0004|cit4","first-page":"21","article-title":"Comparison of 150 IU and 225 IU of follitropin-beta in a fixed-dose regimen for ovarian stimulation using a depot formulation of GnRH agonist: a prospective randomized clinical trial","volume":"10","author":"Cavagna","year":"2006","journal-title":"Jornal Brasileiro de Reproducao Assistida"},{"issue":"1","key":"10.1002\/14651858.CD012693.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(00)01643-5","article-title":"A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-\u03b2) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles","volume":"75","author":"Harrison","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD012693.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1023\/A:1020358419073","article-title":"A group-comparative, randomized, double-blind comparison of the efficacy and efficiency of two fixed daily dose regimens (100- and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for IVF\/ICSI","volume":"19","author":"Hoomans","year":"2002","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1471-0528.2010.02545.x","article-title":"A randomised controlled trial of 300 versus225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count","volume":"117","author":"Jayaprakasan","year":"2010","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","author":"Klinkert","year":"2005","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD012693.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.rbmo.2013.07.008","article-title":"Anti-Mullerian hormone versus antral follicle count for defining the starting dose of FSH","volume":"27","author":"Lan","year":"2013","journal-title":"Reproductive BioMedicine Online"},{"issue":"6","key":"10.1002\/14651858.CD012693.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.fertnstert.2015.08.014","article-title":"450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial","volume":"104","author":"Lefebvre","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD012693.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/humrep\/dex012","article-title":"The addition of anti-M\u00fcllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial","volume":"32","author":"Magnusson","year":"2017","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD012693.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.rbmo.2014.11.013","article-title":"Randomized, controlled, open-label, noninferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa","volume":"30","author":"Olivennes","year":"2015","journal-title":"Reproductive BioMedicine Online"},{"issue":"12","key":"10.1002\/14651858.CD012693.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/humrep\/dex319","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 2: the predicted hyper responder","volume":"32","author":"Oudshoorn","year":"2017","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD012693.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/deh044","article-title":"A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction","volume":"19","author":"Out","year":"2004","journal-title":"Human Reproduction"},{"issue":"11","key":"10.1002\/14651858.CD012693.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/humrep\/deg472","article-title":"A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU\/day in 'standard' patients undergoing IVF\/ICSI treatment","volume":"18","author":"Popovic-Todorovic","year":"2003","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD012693.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10815-005-1497-1","article-title":"A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon R) in women undergoing controlled ovarian hyperstimulation for IVF treatment","volume":"22","author":"Tan","year":"2005","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012693.pub2-BIB0018|cit18","first-page":"i170","article-title":"A randomised controlled trial comparing cycle outcome of individualised versus standard dosage of recombinant FSH with IVF\/ICSI treatment","volume":"25","author":"Tasker","year":"2010","journal-title":"Human Reproduction"},{"issue":"12","key":"10.1002\/14651858.CD012693.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/humrep\/dex318","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: anRCT. Part 1: the predicted poor responder","volume":"32","author":"Tilborg","year":"2017","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD012693.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0015-0282(02)04583-1","article-title":"A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone(Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment","volume":"79","author":"Yong","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012693.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.fertnstert.2009.03.027","article-title":"What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?","volume":"94","author":"Berkkanoglu","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0022|cit22","first-page":"7","article-title":"A multicentre, prospective, randomised study to compare low dose protocol versus conventional administration of Rh-FSH (GONAL-F\u00ae) in normo-responders undergoing ART","volume":"1","author":"Camier","year":"1999","journal-title":"Congress of controversies in Obstestrics, Gynaecology and Infertility"},{"issue":"2","key":"10.1002\/14651858.CD012693.pub2-BIB0023|cit23","first-page":"66","article-title":"A prospective and randomized trial comparing 225IU and 300 IU follitropin-alpha; in a fixed-dose regimen for controlled ovarian stimulation","volume":"24","author":"Cavagna","year":"2009","journal-title":"Jornal Brasileiro de Reproducao Assistida"},{"issue":"5","key":"10.1002\/14651858.CD012693.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0015-0282(00)00414-3","article-title":"A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the \"follicle-stimulating hormone window\" combined with the gonadotropin-releasing hormone antagonist cetrorelix","volume":"73","author":"Jong","year":"2000","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0025|cit25","first-page":"26","article-title":"A prospective randomized clinical trial of four fixed starting doses of recombinant FSH in women undergoing ovarian stimulation for IVF","volume":"15","author":"Fluker","year":"2000","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD012693.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0015-0282(01)02844-8","article-title":"A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro fertilization","volume":"76","author":"Latin-American Puregon IVF Study Group","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0027|cit27","unstructured":"NCT02915900 Optimising FSH dosage during in vitro fertilization (IVF) clinicaltrials.gov\/ct2\/show\/NCT02915900"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/humrep\/14.3.622","article-title":"A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation","volume":"14","author":"Out","year":"1999","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD012693.pub2-BIB0029|cit29","first-page":"29","article-title":"Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes are ovarian stimulation","volume":"15","author":"Out","journal-title":"2000"},{"issue":"6","key":"10.1002\/14651858.CD012693.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/humrep\/16.6.1104","article-title":"A randomized, double-blind clinical trial using fixed daily doses of 100 IU or 200 IU of recombinant FSH in ICSI cycles","volume":"16","author":"Out","year":"2001","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD012693.pub2-BIB0031|cit31","first-page":"1151","article-title":"Comparison of two different fixed doses of follitropin-\u03b2 in controlled ovarian hyperstimulation: a prospective randomized, double blind clinical trial","volume":"87","author":"Pruksananonda","year":"2004","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0032|cit32","first-page":"125","article-title":"A randomized study comparing Puregon 100 IU or 150 IU as starting dose in IVF treatment","volume":"Abstract book 1","author":"Simberg","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0033|cit33","unstructured":"Tsagareishvili G Khonelidze N Lazarev A Results of application of high daily doses of recombinant follicle stimulating hormone in different age groups of women in IVF program Georgian Medical News 2005 11"},{"issue":"8","key":"10.1002\/14651858.CD012693.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/humrep\/16.8.1676","article-title":"A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF\/ICSI","volume":"16","author":"Wikland","year":"2001","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0035|cit35","unstructured":"NCT02309671 A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) \/ Intracytoplasmic Sperm Injection (ICSI) Treatment https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02309671"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0036|cit36","unstructured":"CTRI\/2016\/10\/007367 Phase III Study to Evaluate the Efficacy and Safety of Recombinant Human FSH of Cadila Healthcare Limited, India as compared to Gonal-F Administered Subcutaneously in Female Patients Undergoing Assisted Reproductive Technology http:\/\/ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=16431&EncHid=&userName=CTRI\/2016\/10\/007367"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0037|cit37","unstructured":"EUCT2012-004969-40 An AMH based individualised controlled ovarian stimulation regiment using Corifollitrophin Alphs or graded doses of rFSH versus a standard protocol. A randomised controlled trial www.clinicaltrialsregister.eu\/ctr-search\/trial\/2012-004969-40\/DK"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0038|cit38","unstructured":"NCT01794208 Efficacy and Safety of FSH-GEX\u2122 in Comparison With 150 IU Gonal-f\u00ae https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01794208"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0039|cit39","unstructured":"NCT02430740 Tailored Ovarian Stimulation Based on BMI, AMH, AFC https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02430740"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0040|cit40","unstructured":"NCT02739269 Antimullerian Hormone Versus Antral Follicle Count for Determination of Gonadotrophin Dosing in IVF https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02739269"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0041|cit41","unstructured":"Singh M Singh R Jindal A Jindal PC A prospective randomised controlled trial (RCT) on the role of AMH tailored stimulation protocols (Agonist or Antagonist), in improving IVF outcome in previous failed cycles Human Reproduction 2015 i419-20, P-699"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0042|cit42","unstructured":"Alam V Query on trial: CONSORT vs 150 for FSH dosing Lensen S"},{"issue":"1","key":"10.1002\/14651858.CD012693.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/0974-1208.97795","article-title":"Prediction of ovarian hyperstimulation syndrome in coasted patients in an IVF\/ICSI program","volume":"5","author":"Aljawoan","year":"2012","journal-title":"Journal of Human Reproductive Sciences"},{"issue":"12","key":"10.1002\/14651858.CD012693.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/humrep\/del284","article-title":"Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial","volume":"21","author":"Andersen","year":"2006","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD012693.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertility and sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.fertnstert.2016.08.048","article-title":"Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline","volume":"106","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2016","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0047|cit47","unstructured":"Bastu E Query on trial: 450 vs 300 IU FSH. Eur J Obstet Gynecol Reprod Biol 2016 Lensen S"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0048|cit48","unstructured":"Berkkanoglu M Query on trial: 600 vs 450 vs 300 IU FSH. Fertility and sterility 2010 Lensen S"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/humupd\/dmg045","article-title":"The endometrium in stimulated cycles for IVF","volume":"9","author":"Bourgain","year":"2003","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Human Reproduction Update"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","article-title":"The antral follicle count: practical recommendations for better standardization","volume":"94","author":"Broekmans","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0052|cit52","unstructured":"Broekmans F Query on trial: Klinkert 2005 Lensen S"},{"issue":"2","key":"10.1002\/14651858.CD012693.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD012693.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Human Reproduction Update"},{"issue":"5","key":"10.1002\/14651858.CD012693.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Human Reproduction Update"},{"issue":"8","key":"10.1002\/14651858.CD012693.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/humrep\/dew151","article-title":"Assisted reproductive technology in Europe, 2012: results generated from European registers: results generated from European registers by ESHRE","volume":"31","author":"Calhaz-Jorge","year":"2016","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD012693.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/dew082","article-title":"International committee for monitoring assisted reproductive technologies world report: Assistedreproductive technology 2008, 2009 and 2010","volume":"31","author":"Dyer","year":"2016","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0962280209105014","article-title":"Mediation and moderation of treatment effects in randomised controlled trials of complex interventions","volume":"19","author":"Emsley","year":"2009","journal-title":"Statistical Methods in Medical Research"},{"issue":"4","key":"10.1002\/14651858.CD012693.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.fertnstert.2017.08.016","article-title":"Patient-tailored ovarian stimulation for in vitro fertilization","volume":"108","author":"Fauser","year":"2017","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD012693.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0061|cit61","unstructured":"GRADE Working Group, McMaster University GRADEpro GDT 2014"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.fertnstert.2009.03.102","article-title":"Assisted reproductive technologies (ART) in Canada: 2006 results from the Canadian ART Register","volume":"93","author":"Gunby","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0063|cit63","unstructured":"Hamoda H Query on trial: individualised versus standard dosage of recombinant FSH Lensen S"},{"issue":"10","key":"10.1002\/14651858.CD012693.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/humrep\/deu218","article-title":"Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement","volume":"29","author":"Harbin Consensus Workshop Group","year":"2014","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0065|cit65","unstructured":"Harris K Fitzgerald O Paul R C Macaldowie A Lee E Chambers GM Assisted reproductive technology in Australia and New Zealand 2014 Sydney: National Perinatal Epidemiology and Statistics Unit, the University of New South Wales, 2016"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0066|cit66","unstructured":"Helmgaard L Query on trial: Arce 2017 Lensen S"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0067|cit67","unstructured":"Helmgaard L n\/a Lensen S"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1002\/sim.3427","article-title":"Meta-analysis of skewed data: combining results reported on log-transformed or raw scales","volume":"27","author":"Higgins","year":"2008","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0070|cit70","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0071|cit71","unstructured":"Jayaprakasan K Query on trial: 225 v 300 IU FSH. 2010 Lensen S"},{"issue":"1","key":"10.1002\/14651858.CD012693.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jama.2014.14488","article-title":"Safety of assisted reproductive technology in the United States, 2000-2011","volume":"313","author":"Kawwass","year":"2015","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0015-0282(02)03323-X","article-title":"Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up","volume":"78","author":"Kolibianakis","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD012693.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/humrep\/deu175","article-title":"European IVF-Monitoring Consortium, for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE","volume":"29","author":"Kupka","year":"2014","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD012693.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-0528.2012.03412.x","article-title":"Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles","volume":"119","author":"Marca","year":"2012","journal-title":"BJOG"},{"issue":"1","key":"10.1002\/14651858.CD012693.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"Marca","year":"2014","journal-title":"Human Reproduction Update"},{"issue":"5","key":"10.1002\/14651858.CD012693.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.fertnstert.2017.08.029","article-title":"Female age, serum antim\u00fcllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"108","author":"Marca","year":"2017","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0078|cit78","unstructured":"La Marca A Query on trial: Nomogram for FSH dosing 2017 Lensen S"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0079|cit79","first-page":"5637923","article-title":"A higher ovarian response after stimulation for IVF is related to a higher number of euploid embryos","volume":"2017","author":"Labarta","year":"2017","journal-title":"BioMed Research International"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0080|cit80","unstructured":"Lan TN Query on trial: AMH vs AFC trial for FSH dosing Lensen S"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0081|cit81","unstructured":"Lefebvre J Query on trial: 450 vs 600 IU FSH. Lefebvre 2015 Lensen S"},{"issue":"11-12","key":"10.1002\/14651858.CD012693.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10815-008-9266-6","article-title":"Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve","volume":"25","author":"Lekamge","year":"2008","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0083|cit83","doi-asserted-by":"crossref","unstructured":"Magnusson A Query on trial: Use of AMH in an algorithm for IVF. HR 2017 Lensen S","DOI":"10.1093\/hropen\/hox026"},{"issue":"2","key":"10.1002\/14651858.CD012693.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0093-691X(85)90181-5","article-title":"Superovulation of beef heifers with Pergonal (HMG): a dose response trial","volume":"24","author":"McGowan","year":"1985","journal-title":"Theriogenology"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"issue":"1","key":"10.1002\/14651858.CD012693.pub2-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004379.pub3","article-title":"Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF)","author":"Pandian","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0087|cit87","unstructured":"Popovic-Todorovic B Query on trial 150 vs 100-250 FSH for IVF Lensen S"},{"issue":"1","key":"10.1002\/14651858.CD012693.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1095\/biolreprod.104.032003","article-title":"Follicle-stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitro","volume":"72","author":"Roberts","year":"2005","journal-title":"Biology of Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hropen\/hox018","article-title":"How much variation in oocyte yield after controlled ovarian stimulation can be explained? A multilevel modelling study","volume":"2017","author":"Rustamov","year":"2017","journal-title":"Human Reproduction Open"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum m\u00fcllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012693.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/humupd\/dmq041","article-title":"Clinical outcomes in relation to the daily dose of recombinant follicle stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis","volume":"17","author":"Sterrenburg","year":"2011","journal-title":"Human Reproduction Update"},{"issue":"4","key":"10.1002\/14651858.CD012693.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1292\/jvms.59.223","article-title":"Use of highly purified porcine FSH preparation for superovulation in Japanese black cattle","volume":"59","author":"Sugano","year":"1997","journal-title":"Journal of Veterinary Medical Science"},{"issue":"7","key":"10.1002\/14651858.CD012693.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Human Reproduction"},{"issue":"17","key":"10.1002\/14651858.CD012693.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1158\/1078-0432.CCR-12-3722","article-title":"Trial designs for personalizing cancer care: a systematic review and classification","volume":"19","author":"Tajik","year":"2013","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10.1002\/14651858.CD012693.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.fertnstert.2012.11.037","article-title":"Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach","volume":"99","author":"Thoma","year":"2013","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0097|cit97","unstructured":"Thong KJ Query on trial: 150 v 225 IU FSH. Yong 2003 Lensen S"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.fertnstert.2009.07.054","article-title":"The influence of FSH on the aneuploidy rate of human in vitro matured oocytes","volume":"92","author":"Ting","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0099|cit99","first-page":"556","article-title":"Cumulative live birthrates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols","volume":"32","author":"Toftager","year":"2017","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0100|cit100","unstructured":"Torrance H Query on van Tilborg 2017 Lensen S"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0101|cit101","unstructured":"Trew G Query on study: Out 2004 Lensen S"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/humrep\/deg133","article-title":"Common statistical errors in the design and analysis of subfertility trials","volume":"18","author":"Vail","year":"2003","journal-title":"Human Reproduction"},{"issue":"12","key":"10.1002\/14651858.CD012693.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-M\u00fcllerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"Rooij","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD012693.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/aogs.13032","article-title":"Individualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic review","volume":"95","author":"Tilborg","year":"2016","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD012693.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.1.00529","article-title":"Anti-M\u00fcllerian hormone: a new marker for ovarian function","volume":"131","author":"Visser","year":"2006","journal-title":"Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD012693.pub2-BIB0106|cit106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011184.pub2","article-title":"Fresh versus frozen embryo transfers in assisted reproduction","author":"Wong","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012693.pub2-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001302","article-title":"Volume expanders for the prevention of ovarian hyperstimulation syndrome","author":"Youssef","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012693.pub2-BIB0108|cit108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012693","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing IVF\/ICSI","author":"Lensen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd012693.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012693.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T11:38:39Z","timestamp":1676979519000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012693.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":108,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012693.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD012693.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,1]]}}}